Estudio multidisciplinar de seguimiento del peso corporal en una cohorte de pacientes en tratamiento inicial con antipsicóticos
- Jimeno Bulnes, Natalia
- Velasco González, Verónica
- Escudero García, Antonio
- Guerro Prado, Delio
- Gómez Martínez, Rocío
- Prieto Sanz, Roberto
ISSN: 0210-6523
Argitalpen urtea: 2013
Zenbakia: 50
Orrialdeak: 113-132
Mota: Artikulua
Beste argitalpen batzuk: Anales de la Real Academia de Medicina y Cirugía de Valladolid
Laburpena
Introduction. Weight gain is one of the most troubling adverse effects of atypical anti- psychotics due to their cardiovascular risk and other factors. The main objective is to assess possible changes of body weight and body mass index at 6 months associated with onset of antipsychotic treatment in ordinary clinical use. Methods. It's a cohort, multicentre, prospective study. Results. A cohort of 71 patients treated with antipsychotics was recruited (median=54 years). A total of 60% of patients showed an increase of body weight at the end of the follow- up period. In males (32%, median=37 years), it was obtained that mean body weight at base- line was 74, 9 kg (DE=15,4)and at 6 months 81,1 kg (DE=16,7); mean body mass index at baseline was 25,1 kg/m2 (DE=4,2) and at 6 months 27,1 kg/m2 (DE=4,6). In women (68%, median=61,5 years), it was obtained that mean body weight at baseline was 61,4 kg (DE=10,0) and at 6 months 63, 0 kg (DE=11,2); mean body mass index at baseline 26,6 kg/m2 (DE=4,9) and at 6 months 27,0 kg/m2 (DE=4,6). Increase of body weight over 2 kg was significantly higher in patients under 55 years and males. Conclusions. Onset of antipsychotic treatment in ordinary clinical use is associated with an increase of patients' body weight and body mass index at 6 months, both for men and women. A multidisciplinary research team focused on the study of antipsychotic use of has been established.